Trial NCT03099161

View at ClinicalTrials.gov 
Org. Study IDs: 3814A-062
Secondary IDs: MK-3814A-062

Last trial update was posted on 2019-06-05

MeSH Interventions

Pembrolizumab

MeSH Conditions


Other Conditions

Neoplasm

Stopping Reasons

The data did not support study endpoints

Limitations And Caveats

This study was terminated early because the data did not support the study endpoints.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID